hero section gradient
15 handpicked stocks

King's Ransom

Own the building blocks of our technological future. This collection features carefully selected companies mining and processing rare earth elements - the irreplaceable ingredients powering everything from smartphones to electric vehicles. Handpicked by our expert analysts to capitalize on growing global demand.

Author avatar

Han Tan | Market Analyst

Published on June 17

Your Basket's Financial Footprint

Summary and investor takeaways for the King's Ransom basket based on market capitalisation breakdown.

Key Takeaways for Investors:
  • Large-cap dominance generally implies lower volatility and more market-like, predictable performance versus small-cap growth baskets.
  • Best used as a core portfolio holding rather than speculative, high-risk exposure.
  • Expect steady long-term appreciation; avoid expecting explosive short-term gains.
Total Market Cap
  • MP: $13.12B

  • UUUU: $4.76B

  • METC: $2.48B

  • Other

About This Group of Stocks

1

Our Expert Thinking

Rare earth elements are the unsung heroes behind modern technology. As demand for electric vehicles, renewable energy, and advanced electronics grows, these limited materials become increasingly valuable. We've identified companies positioned to benefit from this accelerating global competition for tech's essential ingredients.

2

What You Need to Know

This portfolio focuses on miners and processors with direct operational control of rare earth elements and strategic metals. These stocks can be volatile but offer significant growth potential as nations worldwide seek to secure supply chains independent from dominant producers, creating a powerful catalyst for sector growth.

3

Why These Stocks

We've selected companies with established production facilities or near-term development projects across the rare earth supply chain. This mix provides exposure to different stages of extraction, processing, and commercialization, prioritizing those with significant projects in regions seeking supply chain independence.

Why You'll Want to Watch These Stocks

🌐

Supply Chain Revolution

Nations are racing to secure their own rare earth supplies, reducing dependence on single sources. This geopolitical shift creates massive opportunities for companies developing new production outside traditional markets.

Hidden Tech Essentials

These aren't household names, but they produce the irreplaceable ingredients in nearly every device you own. As tech demand grows, so does the need for the rare minerals these companies control.

🚀

Green Energy's Secret Ingredient

Want to invest in clean energy's future? These companies provide the critical materials needed for EVs, wind turbines, and energy storage - positioning them at the foundation of the green revolution.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Tech Stocks (AI Valuation Reset) Present Potential Entry

Tech Stocks (AI Valuation Reset) Present Potential Entry

Recent market turmoil, driven by concerns over AI stock valuations, has led to a significant drop in global markets. This correction creates a potential opportunity to invest in fundamentally sound technology companies at more attractive prices.

Walmart Succession Plan Explained | Market Effects

Walmart Succession Plan Explained | Market Effects

Walmart announced a CEO transition, with veteran John Furner taking the helm, which could create opportunities for competitors. This leadership change at a retail giant may cause short-term uncertainty, potentially benefiting other major players in the retail space.

Biotech Buyout Candidates (Post-Merck Acquisition)

Biotech Buyout Candidates (Post-Merck Acquisition)

Merck's $9.2 billion acquisition of Cidara Therapeutics for its antiviral drug pipeline signals a broader industry trend. This creates an investment opportunity in other biotech companies with promising late-stage drugs that could become the next acquisition targets for pharmaceutical giants.

Frequently Asked Questions